Coherus Biosciences Inc

UDENYCA - Cost

Updated as of: July 1st, 2024

HCPCS:

Q5111

HCPCS Code Descriptor:

Injection, pegfilgrastim-cbqv (udenyca), biosimilar, 0.5 mg

Medicare Payment Limit:

The Udenyca Medicare Payment Limit is $166.046.

Average Sale Price:

UDENYCA ASP cost available once logged in. Udenyca is a biosimilar drug making the ASP calculation more complex. Udenyca's ASP is based on the average sale price of its biosimilar reference drug.

Medicare Co-Insurance Percentage:

The Udenyca Medicare Co-Insurance percentage is 20%. Udenyca's Medicare Co-Insurance amount is $33.209

APC Code:

The Udenyca APC Code is: 9195

APC Payment Limit:

The APC Payment Limit for UDENYCA is available. Login to view.

Udenyca Cost Information:

Udenyca is a biosimilar drug to the reference product Neulasta with the active ingredient pegfilgrastim. Udenyca’s HCPCS code Q5111 was added on January 1st, 2019, but did not become effective until April 1st, 2023. Udenyca’s WAC and AWP list prices have remained steady since the drug’s launch while it’s ASP has steadily decreased.

ACCESS PRICING AND MORE BY REGISTERING

Udenyca’s wholesale acquisition cost (WAC) information was last updated on:
May 23, 2023
Udenyca’s average wholesale price (AWP) information was last updated on:
May 23, 2023